Cellectar Biosciences Announces Oversubscribed Financing Up to $140 Million
· inc., cellectar biosciences
AI Briefing
- Cellectar Biosciences secures $140M financing in oversubscribed deal led by Nantahala Capital.
- New investors join existing partners to support company's growth and development.
- Oversubscription demonstrates strong demand for Cellectar Biosciences' innovative solutions.
Advertisement